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Abstract
Objective: Treatment and repair of neurodegenerative diseases such as brain tumors, 
spinal cord injuries, and functional disorders, including Alzheimer’s disease, are chal-
lenging problems. A common treatment approach for such disorders involves the use of 
mesenchymal stem cells (MSCs) as an alternative cell source to replace injured cells. 
However, use of these cells in hosts may potentially cause adverse outcomes such as tu-
morigenesis and uncontrolled differentiation. In attempt to generate mesenchymal derived 
neural cells, we have infected MSCs with recombinant lentiviruses that expressed nerve 
growth factor (NGF) and assessed their neural lineage genes.   
Materials and Methods: In this experimental study, we cloned the NGF gene sequence 
into a helper dependent lentiviral vector that contained the green fluorescent protein (GFP) 
gene. The recombinant vector was amplified in DH5 bacterial cells. Recombinant viruses 
were generated in the human embryonic kidney 293 (HEK-293) packaging cell line with 
the helper vectors and analyzed under fluorescent microscopy. Bone marrow mesenchy-
mal cells were infected by recombinant viruses for three days followed by assessment of 
neural differentiation. We evaluated expression of NGF through measurement of the NGF 
protein in culture medium by ELISA; neural specific genes were quantified by real-time 
polymerase chain reaction (PCR).          
Results: We observed neural morphological changes after three days. Quantitative PCR 
showed that expressions of NESTIN, glial derived neurotrophic factor (GDNF), glial fibril-
lary acidic protein (GFAP) and Microtubule-associated protein 2 (MAP2) genes increased 
following induction of NGF overexpression, whereas expressions of endogenous NGF 
and brain derived neural growth factor (BDNF) genes reduced.                   
Conclusion: Ectopic expression of NGF can induce neurogenesis in MSCs. Direct in-
jection of MSCs may cause tumorigenesis and an undesirable outcome. Therefore an 
alternative choice to overcome this obstacle may be the utilization of differentiated neural 
stem cells.      
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Introduction
Mesenchymal stem cells (MSCs) are multipotent 
stem cells that can differentiate to form osteogenic 
cells, adipocyte cells and chondrocytes. MSCs are 
derived from multiple tissues, bone marrow and 
umbilical cord blood (1, 2). MSCs have useful 
features that make them a unique source for cell 
therapy. These cells can proliferate in vitro, eas-
ily expand and produce adequate numbers of cells. 
The ability to express neurotrophins such as nerve 
growth factor (NGF) and brain derived neural 
growth factor (BDNF) make them an option for 
differentiation into neural cells and achieve de-
sired cells for treatment of certain functional tis-
sue defects. These cells can transdifferentiate into 
several cells under controlled conditions and mod-
ulate the immune system when used in the host. 
Direct injection of MSCs have shown adverse out-
comes in hosts, including tumor formation (3) and 
uncontrolled differentiation into ectopic cells (4, 
5). It is preferable to generate and propagate spe-
cific somatic cells in vitro before infusion. There 
are several procedures for neuronal differentiation 
of MSCs, including the use of growth factors and 
co-culture methods (6).
NGF, the first discovered member of the neuro-
trophins family, is essential for survival, growth and 
differentiation of central and peripheral nerves (7-9). 
NGF is normally expressed in the adult hippocam-
pus and cortex, and provides neurotrophic support 
to cholinergic neurons. This factor plays a critical 
role in the regeneration of peripheral nerves after 
injury. NGF promotes proliferation and differentia-
tion of neural progenitors (10). The administration of 
recombinant β-NGF protein into injured nerves has 
been shown to promote nerve repair and enhance 
functional restoration following nerve damage. Local 
delivery of NGF is problematic due to its short half-
life. In addition, the NGF protein cannot pass through 
the blood brain barrier (11, 12). A useful method for 
treatment of neuronal damage without injections of 
NGF is the in vitro generation of nerve-like cells and 
their direct use for tissue repair.
The present study intended to evaluate the ef-
fect of NGF upregulation on expression of specific 
neural genes. We constructed recombinant repli-
cation-deficient lentiviral vectors that expressed 
human NGF under an eukaryotic promoter in an 
attempt to induce a neuronal differentiation state 
in human bone marrow derived MSCs.
Materials and Methods
This experimental, descriptive study was con-
ducted on human bone marrow derived MSCs that 
were transducted by a recombinant lentiviral vec-
tor which carried the NGF gene.
Construction of the recombinant vector 
We used a commercially prepared human NGF-β 
ORF sequence (pCMV Sport6, Open Biosystems). 
A sequence with 726 nucleotide base pairs was 
amplified from the ORF by pfu DNA polymerase 
(Fermentase Thermo Scientific, USA) and specif-
ic primers (F: 5ʹ-CTAGTCTAGAGCCA CCAT-
GTCCATGTTG TTC TA CAC-3ʹ, R: 5ʹ-CGC 
GGATCC TCAG GCTCTT CTCA CA GCC 
TTCC-3ʹ) that contained Xba1/BamH1 cloning 
sites, respectively. The polymerase chain reaction 
(PCR) conditions were as follows: 4 minutes at 
95˚C (1 cycle), 10 seconds at 95˚C, 15 seconds 
at 64˚C (25 cycles), and 20 seconds at 72˚C (5 
cycles). After digestion, the amplified ORF was 
ligated into a pCDH-CMV-MCS-EF1-copGFP-
CD511B-1 lentiviral vector (System Bioscienc-
es, USA) and confirmed by colony PCR and 
enzymatic mapping. The cloned gene was con-
firmed by sequencing (CMV promoter primer, 
5ʹ-CACGCTGTTTTGACCTCCATAGA-3ʹ).
Generation of recombinant viruses 
We cultured the human embryonic kidney (HEK-
293) cell line (Pasteur Institute, Iran) in 5% CO2 and 
37˚C in a humidified incubator in Dulbecco’s Modi-
fied Eagles’s Medium (DMEM, Invitrogen, USA) 
medium that contained 10% fetal bovine serum 
(FBS) and 1X penicillin/streptomycin (Invitrogen, 
USA). When the cells reached 80% confluency, we 
used lipofectamine 2000 (Invitrogen, USA) to simul-
taneously transfect them with a recombinant plasmid, 
along with pMD2G and PAX2 plasmids (Addgene, 
USA) that encoded a VSV-G envelope and packag-
ing genes onto a 10 cm2 culture plate. A total of 2×105 
293T cells/cm2 were plated in a 10-cm2 plate in 10 ml 
medium and transfected with 21 µg of transfer plas-
mid with the human NGF (hNGF) gene, 10.5 µg pM-
D2G plasmid, and 21 µg PAX2 plasmid. The medium 
was removed approximately 14-16 hours post-trans-
fection and replaced by fresh medium. Cells were col-
lected 24 and 48 hours later, filtered through a 0.45 
µm filter and stored at -80˚C. Expressions of the viral 
genes were monitored by observation of the green 
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fluorescent protein (GFP) under fluorescent micro-
scope (Fig.1). Viral particles were serially titrated and 
we performed flow cytometric analysis as described 
by Gueret et al. (13). Briefly, HEK293 cells were in-
fected by different volumes of the collected viruses 
(10, 50, 100, 150, 250 μl) in 48-well plate. Infected 
cells were detached by trypsinization at 48 hours post-
infection and resuspended in phosphate-buffered 
saline (PBS, Sigma, USA), then analyzed imme-
diately by flow cytometry (Fig.2). Green fluores-
cent units (GFU), as indicators of infective viral 
particles, were calculated according to the follow-
ing formula: [(1×105 seeded cells×% GFP-positive 
cells)×1000]÷volume of diluted viruses (µl).
Fig.1: Fluorescent microscopic evaluation that showed expression of green fluorescent protein (GFP) in transduced cells which suggested 
the existence of recombinant viruses with nerve growth factor (NGF). A, B. Cells at ×10, C. and D. ×40 magnification showed infection of 
mesenchymal stem cells (MSCs) by recombinant viruses that expressed GFP. 
Fig.2: A. Flow cytometric analysis of green fluorescent protein (GFP). Non-infected cells compared to B. 48 hours post-infection which 
showed a high expression level of protein after transduction of the recombinant viruses that carried the GFP sequence.
A B
A B
DC
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Culture and expansion of mesenchymal stem cells
Human bone marrow MSCs were kindly gifted 
by Bonyakhte Stem Cell Research Center (Teh-
ran, Iran). The cells were cultured in low glucose 
DMEM with 10% FBS and 1X penicillin/strepto-
mycin in a T75 cm2 flask at approximately 300×103 
cells per flask. When cells reached greater than 
80% confluency, they were detached by trypsin/
EDTA 0.25% (Sigma, USA), then transferred to 
24-well plates. We changed the medium every 48 
hours. Viability was more than 95% at the time 
of the study, as assessed by 3% trypan blue dye 
(Gibco, Germany).
Detection of recombinant nerve growth factor-β 
We used an ELISA quantitation kit (Human beta-
NGF ELISA kit, Ray Biotech, Inc, USA) to measure 
human NGF levels in culture medium of infected 
cells at days 4 and 7 according to the manufacturer’s 
instructions. Purified hNGF protein was used as the 
standard. Standard and culture extract that contained 
hNGF were incubated on a plate at room temperature 
for 2.5 hours. After washing, biotinylated antibody 
was added and the mixture incubated for one hour at 
room temperature. Detection was performed by using 
streptavidin solution followed by TMB detection on 
an ELISA reader at 450 nm.
Transduction of mesenchymal stem cells
We used ultra-centrifuged concentrated viral parti-
cles at a Multiplicity of infection (MOI) of 10-15 after 
pretest experiments. MSCs were seeded in duplicate 
into 24-well plates in DMEM medium and 5% FBS 
at a density of 5×104 cells per well according to their 
viability. Recombinant viruses were added to the 
culture, while shaking, for 2 hours at 37˚C in a CO2 
incubator. The medium was changed 6 hours after 
transduction. Differentiation was monitored morpho-
logically and analyzed by RT-PCR and real-time PCR 
at 24, 48, and 72 hours after infection of the MSCs.
Quantitative assessment of gene expressions
We harvested the infected cells were harvested at 
pre-determined intervals (24 and 96 hours) and ex-
tracted the total RNA (Qiazole, Qiagene, USA). Brief-
ly, the infected cells were harvested and centrifuged 
at 300 g for 5 minutes. Lysis solution was added to 
the cell pellet with 2 mercaptoethanol (Invitrogen, 
USA) and vortexed twice for 10-15 seconds each, in-
cubated at room temperature, then after centrifugation 
at 11000 g for 1 minute, we added chloroform and 
purified the RNA layer with ethanol. cDNA was syn-
thesized according to the manufacturer’s instructions 
(First Strand cDNA Synthesis Kit, Qiagene, USA). 
Expression of specific neural differentiation was 
quantified by real-time PCR with primers for NGF, 
NESTIN, TUBULIN, Microtubule-associated protein 
2 (MAP2), Glial fibrillary acidic protein (GFAP), 
BDNF, and Glial derived neurotrophic factor (GDNF) 
as shown in Table 1. The fold difference in gene ex-
pression was calculated by the Livak method (2-Δ∆CT). 
Non-transducted cells were used as the control and 
GAPDH as the reference gene. The PCR conditions 
were 10 minutes at 95˚C (1 cycle) followed by 10 sec-
onds at 95˚C, 15 seconds at 60˚C, and 20 seconds at 
72˚C (40 cycles). 
Statistical analysis
All experiments were performed in triplicate. 
We used the average values for relative quantifi-
cation. The results were expressed as mean ± SD 
and analyzed with SPSS 16 software (SPSS Inc., 
IBM, USA). Difference between groups was eval-
uated by Kruskal Wallis and comparison of stud-
ied groups for the expression of the desired genes 
was assessed by the Mann-Whitney test. A P value 
≤0.05 was considered significant.
Ethical consideration
Zanjan University of Medical Sciences Review 
Board and Ethics Committee approved this study. 
Human bone marrow MSCs were kindly gifted and 
characterized for specific mesenchymal markers and 
plasticity by Bonyakhte Stem Cell Research Center 
(Tehran, Iran) at passage-3 post- derivation from 
bone marrow.
Results
Transduction of mesenchymal stem cells 
Human MSCs were cultured in 24-well plates. 
We added the virus supernatant when cells reached 
70-80% confluency. GFP expression was observed 
under inverted fluorescent microscope (Fig.1). The 
percentage of GFP-positive cells after transduction 
approximated 80% at an MOI of 15. The concentra-
tion of viral particles ranged from 5×107 to 8×107 per 
milliliter. There were morphologic changes observed 
under the inverted microscope at 24, 48, and 72 hours 
after transduction (Fig.3). We observed neuronal like 
transformation with stretched extremities and dendrit-
ic shape cells at 48 hours post-treatment.
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Table 1: Specifications of primers used for quantitative real-time polymerase chain reaction (PCR)
Gene Sequence (5´-3´) Length (bp)
GAPDH F: CAAATTCCATGGCACCGT C 62
R: TCTCGCTCCTGGAAGATGGT
H-BDNF F: GTG AATTGA TAATAA ACTGTCCTC 187
R: TAATTCCAACGCTATCAGAAG
H-GDNF F: GAAATAGAAGGCTGGTGAGTG 78
R: ACGACAGGTCATCATCAAAG
H-NGF F: GGACCCAATAACAGTTTTACC 75
R: GAACAACATGGACATTACGC
NESTIN F: GAAGGTGAAGGGCAAATCTG 96
R: CCTCTTCTTCCCATATTTCCTG
GFAP F: GCAGACCTTCTCCAACCTG 127
R: ACTCCTTAATGACCTCTCCATC
MAP2 F: AGTTCCAGCAGCGTGATG 97
R: CATTCTCTCTTCAGCCTTCTC
H-TUBULIN β1 F: GATCGGAGCCAAGTTCTG  177
R: GTCCATCGTCCCAGGTTC
Fig.3: Morphologic changes in mesenchymal stem cells (MSCs) after transduction by recombinant lentiviruses that expressed human 
nerve growth factor (hNGF). Magnification ×40 showed the appearance of membrane extremities in NGF overexpressed cells at 24 and 
48 hours after transduction. A. Non-Transdicted, B. 24 hours, and C. 48 hours post transduction.
A B C
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Quantitative measurement of human nerve 
growth factor protein in culture
The relative levels of hNGF were assessed in 
supernatant of transformed cells by an ELISA kit 
at the suggested time. ELISA assay of the culture 
supernatant revealed stable, high levels of hNGF 
protein (40.5×103 U) under control of the CMV 
promoter (Fig.4). Because of the shorter half-life 
of endogenous NGF mRNA, we performed RT-
PCR at day 4. ELISA was performed at days 0, 
4, and 7. Results showed no significant increase 
in the transducted (1830 pg/ml) and differentia-
tion medium (10340 pg/ml) groups compared to 
the control group (810 pg/ml) on day 4. However 
there was a remarkable increase in NGF observed 
at day 7 for the groups with transducted (4110 pg/
ml) and differentiation (12340 pg/ml) media.
Fig.4: ELISA results of three assayed groups that demonstrated 
the highest level of nerve growth factor (NGF) in supernatant of 
cells cultured in medium that contained NGF. There was a signifi-
cantly high level of NGF expressed in medium of cells infected 
with recombinant viruses that carried the ectopic NGF gene at 
day 7 compared to the control. Control day 0; Non-treated cells, 
Control day 7; Non-treated cells at day 7, Virus day 0; Infected 
cells by recombinant viruses that carried the NGF gene at day 0, 
Virus day 7; Infected cells by recombinant viruses that carried the 
NGF gene at day 7, Neural medium 0; Cells cultured in commer-
cial neural differentiation medium at day 0 and Neural medium 
7; Cells cultured in commercial neural differentiation medium at 
day 7. Results reported as mean ± SD of three experiments. Error 
bars indicate SD. P value≤0.05 was considered significant.
Expression of lineage specific genes
Transformed cells were harvested 96 hours after 
transduction with recombinant viruses that con-
tained hNGF. The expressions of neural specific 
lineage genes were evaluated by quantitative real-
time PCR. Our results showed significant over ex-
pression of neural genes in transformed cells com-
pared with the control group of non-transducted 
cells. As shown in Figure 4, despite stable NGF 
expression in MSCs, ectopic overexpression of 
NGF alone induced neurogenesis in these cells. 
We found that the level of endogenous expressions 
of NESTIN, MAP2, TUBULIN, GFAP and GDNF 
genes increased whereas NGF and BDNF expres-
sions down regulated (Fig.5).
Fig.5: Expression of human nerve growth factor (NGF), NES-
TIN, Microtubule-associated protein 2 (MAP2), Glial fibrillary 
acidic protein (GFAP), TUBULIN β, and Brain derived naural 
growth factor (BDNF) genes assessed on day 4 after transduc-
tion showed reduction in expression of endogenous NGF and 
BDNF. Pre; Day 0 before treatment and Post; 96 hours post-
virus infection. This result showed the role of Glial derived 
neurotrophic factor (GDNF), GFAP, NESTIN, and TUBULIN in the 
final events of neural differentiation. Results reported as mean 
± SD of three experiments.
Discussion
hNGF protein is important for the development 
and survival of neurons, particularly the sensory 
neurons. NGF has been shown to promote the divi-
sion of progenitor cells in rat striatum, as well as 
induce the differentiation of neurons and their pro-
tection under various pathological conditions (14). 
The concentration of NGF in the central nervous 
system is very low. The NGF protein has a molec-
ular weight of approximately 13.2 KD, therefore it 
cannot pass through the blood-brain barrier, which 
restricts its clinical applications (15, 16). Although 
many studies have sought to restore and repair 
neural cell related disorders such as Alzheimer’s 
and conditions such as spinal cord injuries, how-
ever direct administration of the NGF protein is 
not efficient due to the preventive role of the blood 
brain barrier and immunologic issues (17, 18).
Many studies have shown the positive role of 
MSCs in treating spinal cord injuries (19-22). 
Mesenchymal cells can be indefinitely propagated 
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in vitro and differentiate to distinct cell types un-
der controlled conditions. Therefore, these cells 
are suitable sources for cell therapies (22). One 
method for differentiation of MSCs into neuronal 
lineage cells is the use of inducing factors such as 
NGF considering its critical role in neural progres-
sion (23-25).
In the present study, we aimed to demonstrate 
that despite endogenous expression of NGF, 
MSCs could differentiate into a neuronal like state 
through promotion of specific genes of the neural 
lineage. We found that ectopic over expression of 
NGF by recombinant lentiviral vector can itself 
singly induce specific genes of neural lineage. 
NGF assays in culture medium of the three evalu-
ated groups showed a significant increase in NGF 
production after 7 days compared to day 0 in cells 
transducted with viruses that expressed NGF. Al-
though the measured protein in the differentiating 
medium group was high on day 0, there was no 
considerable increase after 7 days, which appeared 
to be due to the existence of NGF in medium rather 
than its endogenous production by cultured cells. 
This finding showed efficient production of NGF 
protein by recombinant viruses and triggered ad-
ditional expression of endogenous gene.
According to our results, recombinant viruses 
that expressed the NGF protein could transdiffer-
entiate MSCs into neuronal like cells without ad-
ditional growth factors in DMEM medium regard-
less of endogenous expression. On day 7, most cell 
populations had transformed and demonstrated 
neuronal like morphology with small cell bodies 
that contained extended processes. Our results con-
firmed the findings of a study that reported mor-
phological transformation 3 hours after induction 
and maximum differentiation after 7 days (26, 27). 
Quantitative evaluation of specific neural genes 4 
days after transduction of recombinant viruses that 
expressed NGF showed decreased levels of en-
dogenous NGF with significantly increased BDNF 
and NESTIN. This finding supported the report by 
Chen et al. regarding the neurogenic roles of NGF, 
BDNF, and fibroblast growth factor (FGF) (28). 
Parivar et al. (29) have reported differentiating 
effects of TUBULIN and basic fibroblast growth 
factor (bFGF) on mouse bone marrow MSCs. 
NGF and related genes, i.e, BDNF overexpress 
during neurogenesis and are essential for this step, 
however they decrease after the  generation of neu-
ronal like cells (30-32). We have observed significant 
increase in GDNF, GFAP, NESTIN, and TUBULIN 
gene expression in cells infected with recombinant 
viruses (P˂0.05), which showed their critical roles in 
the final events of neural differentiation. Our finding 
agreed with previous research on rat bone marrow 
stromal cells (33). The current study also showed that 
expression of NESTIN, a protein that expressed dur-
ing the proliferative state of neural tissues, decreased 
by day 4. Its expression was transient in the initial 
step of neurogenesis; after differentiation and prolif-
eration of neural cells this protein was replaced by 
neural specific filamentous proteins - GFAP, TUBU-
LIN, GDNF, and MAP2 (34, 35). 
Conclusion
We believe these lentiviral based viruses circum-
vent the usual challenges for efficient gene trans-
fer. The recombinant viruses used in the current 
study could promote efficiently neural differenti-
ating genes only by NGF without any additional 
factors. However, for clinical use, safer transfer 
vehicles should be used. Since direct injection of 
MSCs potentially causes tumorigenesis and unde-
sirable outcomes, the best choice to overcome this 
obstacle is utilization of differentiated neural stem 
cells. We believe that the next step should be the 
use of safer approaches to generate neuronal like 
cells by non integrating viral vectors which will 
result in more efficient differentiating methods. 
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